THURSDAY, Oct. 18 (HealthDay News) -- People with Alzheimer's
disease who take the antipsychotic drug risperidone (Risperdal) to
help curb their agitation and aggression may see a return of these
troublesome symptoms if they stop taking the medication, a new
Not every person with Alzheimer's will become agitated and/or
aggressive, but among those who do, these symptoms make it
difficult for caregivers to manage them at home and often lead to
nursing home admission and an increased risk of dying from the
As it stands, these antipsychotic drugs are only supposed to be
taken for three to six months due to concerns about side effects
including weight gain, tremors and movement difficulty. In recent
years, the U.S. Food and Drug Administration also placed a
black-box warning on this class of medications warning that people
with dementia who take antipsychotics have a higher risk of
"Caregivers should be aware of the increased mortality associated with these medications in people with dementia," said study author Dr. D.P. Devanand, director of the division of geriatric psychiatry at Columbia Psychiatry and the New York State Psychiatric Institute in New York City. However, he added, "if a patient is taking an antipsychotic and doing reasonably well without any major side effects, they should stay on it."
The new study, which appears in the Oct. 18 issue of the
New England Journal of Medicine, sought to determine what
happens when the medication is stopped among people who are doing
well on it. The U.S. National Institutes of Health sponsored the
Nursing home staff are tasked with providing written
explanations if they choose to keep someone on one of these
medications for longer than three to six months, Devanand noted.
"One must be cautious about discontinuing the medication. If a
person does well on it and there are not too many side effects,
maybe they should stay on it for a while and be monitored closely,"
Stopping treatment resulted in a relapse of symptoms for those
who had been doing well on the medication for four to eight months,
the investigators found.
The new study included 180 patients with Alzheimer's disease who
showed signs of agitation and aggression. The patients, from eight
U.S. centers, all received risperidone for 16 weeks in the first
phase of the study. After that, the 110 patients who did well on
the drug were assigned to take either risperidone or an inactive
placebo. Those who were switched to a placebo were twice as likely
to relapse when compared to participants who continued taking
risperidone, the study found. What's more, the rate of side effects
and death did not differ among participants.
Dr. Gary Kennedy, director of the division of geriatric
psychiatry at Montefiore Medical Center in New York City, said that
deciding how long to keep a person with Alzheimer's on an
antipsychotic drug isn't an easy decision to make.
But "if a person is responding to the drug, it makes sense to
stick with it," said Kennedy, who was not involved with the
Treating agitation and aggression in someone with Alzheimer's
can make a big difference for the patient and the caregiver, he
added. "These patients can be dangerous and very difficult to care
for," Kennedy noted. "This is a very important study."
Learn more about agitation among people with Alzheimer's disease
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.